Clinical Aspects and Immune Responses in Patients with Long COVID-19

January 25, 2022 | 1:00-3:00 p.m. (CT)

This session seeks to provide a better understanding of long COVID, which affects about 10% of patients who become infected with SARS-CoV-2. Speakers will give a general overview of the pathogenesis of COVID-19, describe clinical aspects of long COVID, address aberrant immune responses in patients with long COVID, and discuss how neurological damage caused by the virus may contribute to persisting symptoms.

Registrants and ASGCT Members: Watch On Demand


Chair: Hildegund Ertl, MD

COVID-19 and Long Covid Pathogenesis

Michael VanElzakker, PhD
Harvard Medical School/Massachusetts General Hospital

Clinical Aspects of Long COVID - Clinical Aspects (from Patient Characteristics and Symptoms)

Linda Geng, MD, PhD
Stanford University

Neurologic Manifestations of COVID-19

Igor Koralnik, MD
Northwestern University

Immune Response Induced Long COVID

Timothy Henrich, MD


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.